Centene (CNC) Reports Q4 Loss, Beats Revenue Estimates

Core Insights - Centene reported a quarterly loss of $1.19 per share, which was better than the Zacks Consensus Estimate of a loss of $1.25, marking an earnings surprise of +4.76% [1] - The company generated revenues of $49.73 billion for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 3.08% and showing a year-over-year increase from $40.81 billion [2] Financial Performance - Over the last four quarters, Centene has surpassed consensus EPS estimates three times and topped revenue estimates four times [2] - The current consensus EPS estimate for the upcoming quarter is $1.93 on revenues of $48 billion, and for the current fiscal year, it is $2.89 on revenues of $191.31 billion [7] Market Position - Centene shares have declined about 3% since the beginning of the year, while the S&P 500 has only declined by 0.7% [3] - The Zacks Industry Rank for Medical - HMOs, which includes Centene, is currently in the bottom 7% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8] Future Outlook - The company's earnings outlook will be crucial for determining the stock's immediate price movement, with management's commentary on the earnings call being particularly important [3][4] - The estimate revisions trend for Centene was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, suggesting expected underperformance in the near future [6]